| Cyprus | Turkey | Austria | |
| Therapeutic Apheresis | - | from $1,350 | - |
| Plasmapheresis | - | from $1,200 | from $2,000 |
| Plasma Exchange | - | from $3,900 | - |
| Ocrevus (ocrelizumab) | - | from $10,000 | from $35,000 |
| Multiple sclerosis rehabilitation | - | from $3,000 | from $10,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Multiple sclerosis treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Multiple sclerosis treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Multiple sclerosis treatment journey.
Multiple sclerosis treatment in Cyprus is safe for standard disease-modifying therapies like Tecfidera. Neurologists are typically EU-trained and follow European Medicines Agency protocols. For complex cases or advanced infusions like Ocrevus, patients should confirm the specialist's specific high-volume experience and international memberships.
Bookimed Expert Insight: While local clinics like German Medical Institute serve 13,000+ patients annually, neurology infrastructure is specialized. Data suggests Cyprus is excellent for routine maintenance and diagnostic check-ups. For aggressive MS or clinical trials, patients often combine local care with specialized centers in Germany or Israel.
Patient Consensus: Patients note that while local doctors are highly qualified, finding a dedicated MS specialist is essential. Many recommend verifying if a neurologist frequently handles specialized infusions before starting treatment.
Multiple sclerosis patients in Cyprus access disease-modifying therapies like ocrelizumab (Ocrevus) and interferon beta-1a through the GESY public health system. Treatment protocols include plasmapheresis and specialized rehabilitation at facilities like German Medical Institute. Access to advanced oral medications often requires specific clinical progression documentation.
Bookimed Expert Insight: Data shows a clear logistical split between Nicosia and Limassol clinics. While Nicosia centers handle high public volumes, private facilities like German Medical Institute serve 13,700 patients annually. Choosing private care in Limassol typically bypasses the 3-month wait times common in public systems.
Patient Consensus: Patients note that while basic injectables are free, securing newer oral drugs requires meticulous symptom tracking. Many emphasize starting the GESY approval process early to avoid long queues at major state clinics.
DMTs in Cyprus typically cause mild flu-like symptoms, including fever, chills, and muscle aches. Patients often experience these within 48 hours of infusion. Long-term risks include increased susceptibility to infections like shingles or UTIs. Specialist centers in Cyprus use advanced monitoring to ensure safety.
Bookimed Expert Insight: Cyprus offers a unique advantage for MS patients through facilities like German Medical Institute. This center treats 13,700 patients annually and holds CHKS accreditation for healthcare data management. This specific certification ensuring rigorous data tracking is vital for monitoring long-term DMT safety profiles. Reliable data management helps doctors spot subtle side-effect patterns across large patient groups.
Patient Consensus: Many patients find that taking aspirin or Tylenol before treatment helps manage initial chills. They also emphasize staying extra hydrated to handle the Mediterranean heat during recovery periods.
Cypriot hospitals primarily offer standard neurological care and specialized rehabilitation for aggressive Multiple Sclerosis. While clinics provide advanced medications and plasmapheresis, they do not currently perform Hematopoietic Stem Cell Transplantation (HSCT). Patients requiring cellular therapies are typically referred to specialized bone marrow transplant units abroad.
Bookimed Expert Insight: While Cyprus excels in neuro-rehabilitation, the infrastructure for HSCT requires specific bone marrow transplant certifications. Data shows German Medical Institute handles 13,700 patients annually with 90 doctors. However, their focus remains on oncology and nuclear medicine rather than complex cellular neurology. Patients seeking HSCT often utilize the Republic of Cyprus as a base for diagnosis before traveling to high-volume centers in Israel or Italy.
Patient Consensus: Patients note that while Nicosia has strong neurology departments, they typically focus on standard infusions. Many emphasize that for HSCT, you should expect a referral to larger EU-approved clinical sites.